Employment of individuals who lawfully consume cannabis; protection; employment; effective date.
HB 1714 creates a new section of Oklahoma law protecting certain job applicants from discrimination based on lawful off-duty cannabis use or the presence of nonpsychoactive cannabis metabolites in preemployment drug tests. The bill makes it unlawful for an employer to deny initial employment solely because an applicant used cannabis away from the workplace or tested positive for cannabis metabolites in hair, blood, urine, or other bodily fluids. It defines “cannabis” broadly, while carving out hemp, FDA-approved drugs, and certain cannabidiol products used for specified medical conditions.
The bill preserves employer authority in several important areas. It does not prevent employers from maintaining drug- and alcohol-free workplaces, from complying with federal law or regulation, or from using scientifically valid testing methods that do not screen for nonpsychoactive cannabis metabolites. It also excludes applicants for positions requiring federal background investigations or security clearances, airline and aerospace jobs, and other safety-sensitive positions involving a substantial risk of death. The bill further states that it does not override state or federal testing requirements tied to employment, federal funding, licensing benefits, or federal contracts.
In practical terms, HB 1714 would add a new employment-protection provision to Title 63 of the Oklahoma Statutes, limiting how employers may use cannabis-related test results in hiring decisions. It would not broadly legalize cannabis use in the workplace, but it would restrict preemployment discrimination against applicants who lawfully consume cannabis off duty. The measure is scheduled to take effect November 1, 2025.
Because there are no committee transcripts or recorded votes provided, the available context shows little direct public debate in the materials supplied. The bill’s structure suggests a balancing approach: it expands protections for lawful cannabis consumers while explicitly preserving employer testing and safety-related exceptions. The main likely point of contention is the tension between employee privacy and off-duty conduct protections on one hand, and employer concerns about workplace safety, federal compliance, and drug-free hiring standards on the other.
HB 1714 would amend Oklahoma law by creating Section 427.28a of Title 63, establishing a statutory prohibition on employment discrimination in initial hiring based on lawful off-duty cannabis use or preemployment test results showing nonpsychoactive cannabis metabolites. It would also define cannabis for purposes of the section and incorporate exceptions for hemp, FDA-approved products, certain medical cannabidiol use, and federally regulated or safety-sensitive positions. Employers would retain authority to conduct drug testing and enforce workplace drug policies, but would be limited in using cannabis metabolite results to deny employment.
The bill appears to reflect a generally supportive or reform-oriented approach toward cannabis users in the employment context, while still accommodating employer and federal compliance concerns. The text is carefully drafted to avoid broad disruption of existing workplace drug policies, suggesting an attempt to balance competing interests rather than a sweeping change. No votes or committee testimony are provided, so there is no documented opposition or endorsement in the supplied materials beyond the bill’s own compromise structure.
The central point of contention is likely whether employers should be barred from considering off-duty cannabis use or metabolite-positive preemployment tests when making hiring decisions. Employee advocates would likely favor the bill’s anti-discrimination protections, while employers, safety-sensitive industries, and entities subject to federal drug-testing rules may be concerned about operational safety, liability, and compliance burdens. The bill addresses some of those concerns through exceptions for federal clearances, airline and aerospace jobs, other safety-sensitive positions, and federally mandated testing, but those carveouts also indicate where debate would most likely focus.